TetraVax-DV-TV003 (TV003)

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

DengueZika Virus

Phase 1

Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge

CompletedNCT03416036

National Institute of Allergy and Infectious Diseases (NIAID)Dengue

Start: 2017-11-28End: 2019-06-04Updated: 2020-01-18

Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge

CompletedNCT06805487

National Institute of Allergy and Infectious Diseases (NIAID)Zika Virus

Start: 2024-09-24End: 2025-09-15Updated: 2026-03-09